Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Thursday, December 12, 2024.
Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI)
Weak Downtrend (-65) - BCLI is showing signs of a strengthening downtrend. Monitor BCLI as it may be building momentum to the downside.
Is it time to buy, sell, or avoid BCLI?
MarketClub looks at technical strength and momentum to determine if the timing is right for BCLI.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for BCLI
The long-term trend has been DOWN since Aug 2nd, 2024 at 0.3100
The intermediate-term trend has been DOWN since Sep 6th, 2024 at 0.2693
The short-term trend has been UP since Dec 9th, 2024 at 1.6900
Smart Scan Analysis for BCLI
Based on our trend formula, BCLI is rated as a -65 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 1.59 | 1.64 | 1.54 | 1.58 | -0.03 |
| Prev. Close | Volume | Bid | Ask | Time |
| 1.60 | 30109 | 2024-12-11 15:59:52 |
| Year High | 5.35 | Year High Date | 2018-06-04 |
| Year Low | 2.88 | Year Low Date | 2018-02-09 |
| 52wk High | 11.890485 | 52wk High Date | 2024-03-25 |
| 52wk Low | 1.05 | 52wk Low Date | 2024-11-14 |
| Year End Close | 0.223 | Average Volume | 108,619 |
| Shares Outstanding | 5,703 | % Institutional | 19.6 |
| Market Cap | 91M | Assets | 2,025,000M |
| Liabilities | 8,082,000M | P/E Ratio | -0.94200000 |
| Beta | 0.8 | Volatility | 39.71 |